The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Howard, A. D.
Right arrow Articles by Tocci, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Howard, A. D.
Right arrow Articles by Tocci, M. J.

The Journal of Immunology, Vol 154, Issue 5 2321-2332, Copyright © 1995 by American Association of Immunologists


ARTICLES

Human IL-1 beta processing and secretion in recombinant baculovirus- infected Sf9 cells is blocked by the cowpox virus serpin crmA

AD Howard, OC Palyha, PR Griffin, EP Peterson, AB Lenny, GJ Ding, DJ Pickup, NA Thornberry, JA Schmidt and MJ Tocci
Department of Immunology, Merck Research Laboratories, Rahway, NJ 07065.

Biologically active, mature IL-1 beta (mIL-1 beta) is released from activated monocytes after proteolytic processing from an inactive precursor (pIL-1 beta). IL-1 beta converting enzyme (ICE), the first member of a newly discovered family of cysteine proteinases, is required for this processing event. The cleaved cytokine is released from monocytes by an unknown mechanism which does not employ a standard hydrophobic signal sequence. As in mammalian fibroblasts, insect Sf9 cells do not normally process or secrete human IL-1 beta. The expression of active ICE enables Sf9 cells to process 31-kDa pIL-1 beta correctly at Asp27 and Asp116, and to export 17.5-kDa mIL-1 beta. The recombinant heterodimeric human enzyme purified from Sf9 cells possesses a sp. act. of 2.9 +/- 0.5 x 10(6) U/mg and is indistinguishable from native ICE with regard to its subunit composition and catalytic properties. In this system, co-expression of the cowpox virus crmA gene, an extremely potent serpin inhibitor of ICE (Ki < 7 pM), inhibits ICE activation completely and blocks pIL-1 beta processing and mIL-1 beta secretion by approximately 95%. The results indicate that ICE, in addition to its processing function, facilitates the transport of IL-1 beta across the plasma membrane.


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
A. Iannello, O. Debbeche, E. Martin, L. H. Attalah, S. Samarani, and A. Ahmad
Viral strategies for evading antiviral cellular immune responses of the host
J. Leukoc. Biol., January 1, 2006; 79(1): 16 - 35.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
U. Schonbeck, F. Mach, J.-Y. Bonnefoy, H. Loppnow, H.-D. Flad, and P. Libby
Ligation of CD40 Activates Interleukin 1beta -converting Enzyme (Caspase-1) Activity in Vascular Smooth Muscle and Endothelial Cells and Promotes Elaboration of Active Interleukin 1beta
J. Biol. Chem., August 1, 1997; 272(31): 19569 - 19574.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Van Criekinge, R. Beyaert, M. Van de Craen, P. Vandenabeele, P. Schotte, D. De Valck, and W. Fiers
Functional Characterization of the Prodomain of Interleukin1beta -converting Enzyme
J. Biol. Chem., November 1, 1996; 271(44): 27245 - 27248.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T.-T. Yamin, J. M. Ayala, and D. K. Miller
Activation of the Native 45-kDa Precursor Form of Interleukin-1-converting Enzyme
J. Biol. Chem., May 31, 1996; 271(22): 13273 - 13282.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.